G R Braslawsky - JoVE Visualize

Showing results (11-20 of 21) with videos related to

Pageof 3

Sort By:

Cancer Research|October 15, 1990

Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killingG R Braslawsky, M A Edson, W Pearce, et al.

Bioconjugate Chemistry|November 1, 1992

Determination of immunoreactivity of doxorubicin antibody immunoconjugates by a Le(y) competitive RIAH Zhao, D Willner, J S Cleaveland, et al.

Hybridoma|January 1, 1983

Direct binding of radioiodinated monoclonal antibody to tumor cells: significance of antibody purity and affinity for drug targeting or tumor imagingS J Kennel, L J Foote, P K Lankford, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1991

Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activityG R Braslawsky, K Kadow, J Knipe, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1993

Identification of functional domains in murine granulocyte-macrophage colony-stimulating factor using monoclonal antibodies to synthetic peptidesR S Greenfield, G R Braslawsky, K F Kadow, et al.

Bioconjugate Chemistry|May 1, 1991

New hydrazone derivatives of adriamycin and their immunoconjugates--a correlation between acid stability and cytotoxicityT Kaneko, D Willner, I Monkovíc, et al.

Bioconjugate Chemistry|July 1, 1992

Cytotoxicity of chimeric (human-murine) monoclonal antibody BR96 IgG, F(ab')2, and Fab' conjugated to Pseudomonas exotoxinC B Siegall, S L Gawlak, J J Chin, et al.

Cancer Research|October 15, 1992

Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft modelsP A Trail, D Willner, S J Lasch, et al.

Cancer Research|October 15, 1990

Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linkerR S Greenfield, T Kaneko, A Daues, et al.

Bioconjugate Chemistry|November 1, 1993

(6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicinD Willner, P A Trail, S J Hofstead, et al.

Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:

Pageof 3

Cancer Research|October 15, 1990

Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killingG R Braslawsky, M A Edson, W Pearce, et al.

Bioconjugate Chemistry|November 1, 1992

Determination of immunoreactivity of doxorubicin antibody immunoconjugates by a Le(y) competitive RIAH Zhao, D Willner, J S Cleaveland, et al.

Hybridoma|January 1, 1983

Direct binding of radioiodinated monoclonal antibody to tumor cells: significance of antibody purity and affinity for drug targeting or tumor imagingS J Kennel, L J Foote, P K Lankford, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1991

Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activityG R Braslawsky, K Kadow, J Knipe, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1993

Identification of functional domains in murine granulocyte-macrophage colony-stimulating factor using monoclonal antibodies to synthetic peptidesR S Greenfield, G R Braslawsky, K F Kadow, et al.

Bioconjugate Chemistry|May 1, 1991

New hydrazone derivatives of adriamycin and their immunoconjugates--a correlation between acid stability and cytotoxicityT Kaneko, D Willner, I Monkovíc, et al.

Bioconjugate Chemistry|July 1, 1992

Cytotoxicity of chimeric (human-murine) monoclonal antibody BR96 IgG, F(ab')2, and Fab' conjugated to Pseudomonas exotoxinC B Siegall, S L Gawlak, J J Chin, et al.

Cancer Research|October 15, 1992

Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft modelsP A Trail, D Willner, S J Lasch, et al.

Cancer Research|October 15, 1990

Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linkerR S Greenfield, T Kaneko, A Daues, et al.

Bioconjugate Chemistry|November 1, 1993

(6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicinD Willner, P A Trail, S J Hofstead, et al.

Pageof 3